 Shares of Health Catalyst NASDAQ:HCAT fell 8.31 in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share rose 28.57 over the past year to 0.15, which beat the estimate of 0.22.Revenue of 43,259,000 rose by 17.54 year over year, which beat the estimate of 42,140,000.Looking Ahead Earnings guidance hasnt been issued by the company for now.The upcoming fiscal years revenue expected to be between 177,200,000 and 181,200,000.Conference Call Details Date: Aug 11, 2020View more earnings on HCATTime: 05:00 PMET Webcast URL: Companys 52-week high was at 49.85Companys 52-week low was at 17.48Price action over last quarter: Up 23.50Company Profile Health Catalyst Inc is engaged in providing data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, which is the key revenue driver, includes data platform, analytics applications and support services. This generates revenues primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; and Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.See more from Benzinga Earnings Scheduled For August 11, 2020 Benzingas Top Upgrades, Downgrades For June 18, 2020C 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. 